167 related articles for article (PubMed ID: 32856851)
1. Telomerase as a Possible Candidate Targeting Therapy in Different Breast Cancer Cell Lines.
Aboelela S; Ashmawy A; Shaarawy S; El-Hefny M; Medhat A
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2243-2250. PubMed ID: 32856851
[TBL] [Abstract][Full Text] [Related]
2. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.
Dong X; Liu A; Zer C; Feng J; Zhen Z; Yang M; Zhong L
BMC Cancer; 2009 May; 9():133. PubMed ID: 19416503
[TBL] [Abstract][Full Text] [Related]
3. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
Sakin V; Eskiocak U; Kars MD; Iseri OD; Gunduz U
Exp Oncol; 2008 Sep; 30(3):202-5. PubMed ID: 18806742
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
Rao Y; Xiong W; Liu H; Jia C; Zhang H; Cui Z; Zhang Y; Cui J
Breast Cancer; 2016 Mar; 23(2):216-23. PubMed ID: 25098685
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
Bashash D; Zareii M; Safaroghli-Azar A; Omrani MD; Ghaffari SH
Hematology; 2017 Jul; 22(6):330-340. PubMed ID: 28054503
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells.
El Habre R; Aoun R; Tahtouh R; Hilal G
BMC Cancer; 2024 May; 24(1):615. PubMed ID: 38773429
[TBL] [Abstract][Full Text] [Related]
7. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.
Liu L; Li H; Zhang M; Lv X
Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo.
Lanvers-Kaminsky C; Winter B; Koling S; Frodermann B; Braun Y; Schaefer KL; Diallo R; Koenemann S; Wai D; Willich N; Poremba C; Schuck A
Oncol Rep; 2005 Sep; 14(3):751-8. PubMed ID: 16077987
[TBL] [Abstract][Full Text] [Related]
9. Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231.
Konieczna N; Romaniuk-Drapała A; Lisiak N; Totoń E; Paszel-Jaworska A; Kaczmarek M; Rubiś B
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151281
[TBL] [Abstract][Full Text] [Related]
10. hTERT Downregulation Attenuates Resistance to DOX, Impairs FAK-Mediated Adhesion, and Leads to Autophagy Induction in Breast Cancer Cells.
Romaniuk-Drapała A; Totoń E; Konieczna N; Machnik M; Barczak W; Kowal D; Kopczyński P; Kaczmarek M; Rubiś B
Cells; 2021 Apr; 10(4):. PubMed ID: 33920284
[TBL] [Abstract][Full Text] [Related]
11. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
[TBL] [Abstract][Full Text] [Related]
12. siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468).
Vahidian F; Safarzadeh E; Mohammadi A; Najjary S; Mansoori B; Majidi J; Babaloo Z; Aghanejad A; Shadbad MA; Mokhtarzadeh A; Baradaran B
Mol Biol Rep; 2020 Dec; 47(12):9541-9551. PubMed ID: 33206362
[TBL] [Abstract][Full Text] [Related]
13. Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes.
Alkaraki A; Alshaer W; Wehaibi S; Gharaibeh L; Abuarqoub D; Alqudah DA; Al-Azzawi H; Zureigat H; Souleiman M; Awidi A
Breast Cancer; 2020 Sep; 27(5):989-998. PubMed ID: 32328816
[TBL] [Abstract][Full Text] [Related]
14. [Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line].
Cheng W; Su Y; Ma HQ; Wei ZF; Gao JP; Zhang ZY; Ge JP; Jing KZ; Xu F
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2847-52. PubMed ID: 20137667
[TBL] [Abstract][Full Text] [Related]
15. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of adriamycin cytotoxicity by sodium butyrate involves hTERT downmodulation-mediated apoptosis in human uterine cancer cells.
Yu M; Kong H; Zhao Y; Sun X; Zheng Z; Yang C; Zhu Y
Mol Carcinog; 2014 Jul; 53(7):505-13. PubMed ID: 23359532
[TBL] [Abstract][Full Text] [Related]
17. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A
Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of interference hTERT and TRF2 gene on the growth of breast cancer MCF-7 cells].
Chen SK; Liu L; Shui QL; Yu H; Zeng YQ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):93-7. PubMed ID: 20403237
[TBL] [Abstract][Full Text] [Related]
19. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
Daniel M; Tollefsbol TO
J Cell Biochem; 2018 Apr; 119(4):3326-3337. PubMed ID: 29125889
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA La-related RNA-binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancer.
Zhang X; Su X; Guo Z; Jiang X; Li X
J Clin Lab Anal; 2020 Jul; 34(7):e23272. PubMed ID: 32187743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]